Literature DB >> 33159240

N-Methyl-D-aspartate receptor activation, novel mechanism of homocysteine-induced blood-retinal barrier dysfunction.

Amany Tawfik1,2,3,4, Riyaz Mohamed5, Dina Kira6,7, Suhib Alhusban6,7, Mohamed Al-Shabrawey6,7,8,9.   

Abstract

Elevated levels of amino acid homocysteine (Hcy) recognized as hyperhomocysteinemia (HHcy) was reported in several human visual disorders, such as diabetic retinopathy (DR) and age-related macular degeneration (AMD). Breakdown of blood-retinal barrier (BRB) is concomitant with vision loss in DR and AMD. We previously reported that HHcy alters BRB. Here, we tested the hypothesis that HHcy alters BRB via activation of N-methyl-D-aspartate receptor (NMDAR). Human retinal endothelial cells subjected to high level of Hcy and mouse model of HHcy were used. We injected Hcy intravitreal and used a mouse model of HHcy that lacks cystathionine-β-synthase (CBS). RT-PCR, western blot, and immunofluorescence showed that retinal endothelial cells (RECs) express NMDAR at the gene and protein levels both in vitro and in vivo and this was increased by HHcy. We assessed BRB function and retinal morphology using fluorescein angiogram and optical coherence tomography (OCT) under HHcy with and without pharmacological inhibition of NMDAR by (MK801) or in mice lacking endothelial NMDAR (NMDARE-/- mouse). Additionally, retinal albumin leakage and tight junction proteins ZO-1 and occludin were assessed by western blotting analysis. Inhibition or elimination of NMDAR was able to improve the altered retinal hyperpermeability and morphology under HHcy as indicated by significant decrease in retinal albumin leakage and restoration of tight junction proteins ZO-1 and occludin. Our findings underscore a potential role for endothelial NMDAR in mediating Hcy-induced breakdown of BRB and subsequently as a potential therapeutic target in retinal diseases associated with HHcy such as DR and AMD. KEY MESSAGES: • Elevated levels of homocysteine (Hcy) are defined as hyperhomocysteinemia (HHcy). • HHcy is implicated in diabetic retinopathy and age-related macular degeneration. • HHcy alters BRB via activation of N-methyl-D-aspartate receptor.

Entities:  

Keywords:  Blood–retinal barrier; Cystathionine-β—synthase and mouse; Homocysteine; N-Methyl-D-aspartate receptor

Mesh:

Substances:

Year:  2020        PMID: 33159240      PMCID: PMC7785674          DOI: 10.1007/s00109-020-02000-y

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  72 in total

1.  Hyperhomocysteinemia leads to exacerbation of ischemic brain damage: Role of GluN2A NMDA receptors.

Authors:  Ankur Jindal; Sathyanarayanan Rajagopal; Lucas Winter; Joshua W Miller; Donald W Jacobsen; Jonathan Brigman; Andrea M Allan; Surojit Paul; Ranjana Poddar
Journal:  Neurobiol Dis       Date:  2019-03-15       Impact factor: 5.996

2.  Effects of blockade of ionotropic glutamate receptors on blood-brain barrier disruption in focal cerebral ischemia.

Authors:  Xia Liu; Christine Hunter; Harvey R Weiss; Oak Z Chi
Journal:  Neurol Sci       Date:  2010-03-09       Impact factor: 3.307

3.  Apoptotic cell death in the mouse retinal ganglion cell layer is induced in vivo by the excitatory amino acid homocysteine.

Authors:  P Moore; A El-sherbeny; P Roon; P V Schoenlein; V Ganapathy; S B Smith
Journal:  Exp Eye Res       Date:  2001-07       Impact factor: 3.467

4.  The role of N-methyl-D-aspartate receptor activation in homocysteine-induced death of retinal ganglion cells.

Authors:  Preethi S Ganapathy; Richard E White; Yonju Ha; B Renee Bozard; Paul L McNeil; R William Caldwell; Sanjiv Kumar; Stephen M Black; Sylvia B Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-25       Impact factor: 4.799

5.  Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia.

Authors:  M Watanabe; J Osada; Y Aratani; K Kluckman; R Reddick; M R Malinow; N Maeda
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

Review 6.  Rationale for and use of NMDA receptor antagonists in Parkinson's disease.

Authors:  Penelope J Hallett; David G Standaert
Journal:  Pharmacol Ther       Date:  2004-05       Impact factor: 12.310

7.  Lack of association between serum homocysteine level and middle cerebral artery stenosis.

Authors:  Haitao Zhou; Chao Huang; Ruihua Liu; Chao Liu; Congmin Ma; Xiangyang Ren
Journal:  Brain Behav       Date:  2019-06-21       Impact factor: 2.708

8.  Folate status in type 2 diabetic patients with and without retinopathy.

Authors:  Giulia Malaguarnera; Caterina Gagliano; Salvatore Salomone; Maria Giordano; Claudio Bucolo; Antonino Pappalardo; Filippo Drago; Filippo Caraci; Teresio Avitabile; Massimo Motta
Journal:  Clin Ophthalmol       Date:  2015-08-07

9.  Hyperhomocysteinemia disrupts retinal pigment epithelial structure and function with features of age-related macular degeneration.

Authors:  Ahmed S Ibrahim; Suchreet Mander; Khaled A Hussein; Nehal M Elsherbiny; Sylvia B Smith; Mohamed Al-Shabrawey; Amany Tawfik
Journal:  Oncotarget       Date:  2016-02-23

Review 10.  Association between homocysteine level and the risk of diabetic retinopathy: a systematic review and meta-analysis.

Authors:  Xunwen Lei; Guifeng Zeng; Yuemei Zhang; Qiang Li; Jinzhi Zhang; Zhenggang Bai; Kehu Yang
Journal:  Diabetol Metab Syndr       Date:  2018-08-02       Impact factor: 3.320

View more
  3 in total

Review 1.  Wnt Signaling in Inner Blood-Retinal Barrier Maintenance.

Authors:  Felix Yemanyi; Kiran Bora; Alexandra K Blomfield; Zhongxiao Wang; Jing Chen
Journal:  Int J Mol Sci       Date:  2021-11-02       Impact factor: 6.208

2.  Implication of N-Methyl-d-Aspartate Receptor in Homocysteine-Induced Age-Related Macular Degeneration.

Authors:  Yara A Samra; Dina Kira; Pragya Rajpurohit; Riyaz Mohamed; Leah A Owen; Akbar Shakoor; Ivana K Kim; Margaret M DeAngelis; Nader Sheibani; Mohamed Al-Shabrawey; Amany Tawfik
Journal:  Int J Mol Sci       Date:  2021-08-28       Impact factor: 5.923

Review 3.  Homocysteine and Age-Related Central Nervous System Diseases: Role of Inflammation.

Authors:  Amany Tawfik; Nehal M Elsherbiny; Yusra Zaidi; Pragya Rajpurohit
Journal:  Int J Mol Sci       Date:  2021-06-10       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.